| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $2.4M | -13.4% | +34.5% |
| SG&A Expense | $2.0M | +0.3% | -24.8% |
| Operating Income | -$4.4M | +7.6% | +0.9% |
| Net Income | -$4.9M | +10.4% | -14.9% |
| EPS (Basic) | -$9.10 | +85.3% | — |
| EPS (Diluted) | -$9.10 | +85.3% | — |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.9M | -40.6% | — |
| Current Assets | $2.6M | -39.9% | -31.2% |
| Total Assets | $3.9M | -36.9% | -39.8% |
| Current Liabilities | $8.5M | +11.0% | -10.3% |
| Total Liabilities | $8.5M | +7.9% | -17.1% |
| Stockholders' Equity |
| -$4.5M |
| -178.1% |
| -22.7% |